Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Geier

Showing results (51-60 of 125) with videos related to

Pageof 13
Sort By:
Journal of Toxicology and Environmental Health. Part A|January 16, 2010
A prospective blinded evaluation of urinary porphyrins verses the clinical severity of autism spectrum disordersDavid A Geier, Janet K Kern, Mark R Geier
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 29, 2010
The relative toxicity of compounds used as preservatives in vaccines and biologicsDavid A Geier, Sarah K Jordan, Mark R Geier
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 30, 2016
A Two-Phase Case-Control Study of Autism Risk Among Children Born From the Late 1990s Through the Early 2000s in the United StatesDavid A Geier, Janet K Kern, Mark R Geier
Toxics|November 18, 2018
Premature Puberty and Thimerosal-Containing Hepatitis B Vaccination: A Case-Control Study in the Vaccine Safety DatalinkDavid A Geier, Janet K Kern, Mark R Geier
Acta Neurobiologiae Experimentalis|July 14, 2009
A prospective study of prenatal mercury exposure from maternal dental amalgams and autism severityDavid A Geier, Janet K Kern, Mark R Geier
Acta Neurobiologiae Experimentalis|July 15, 2010
The biological basis of autism spectrum disorders: Understanding causation and treatment by clinical geneticistsDavid A Geier, Janet K Kern, Mark R Geier
Expert Opinion on Drug Safety|August 9, 2003
A review of hepatitis B vaccinationMark R Geier, David A Geier, Arthur C Zahalsky
Journal of the Neurological Sciences|May 17, 2008
Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety DatalinkHeather A Young, David A Geier, Mark R Geier
Developmental Neurobiology|November 20, 2019
Down syndrome as a genetic model to evaluate the role of oxidative stress and transsulfuration abnormalities in autism spectrum disorder: A 10-year longitudinal cohort studyDavid A Geier, Janet K Kern, Mark R Geier
Maedica|February 13, 2013
A prospective Cross-sectional Cohort Assessment of Health, Physical, and Behavioral Problems in Autism Spectrum DisordersDavid A Geier, Janet K Kern, Mark R Geier
Pageof 13

Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
Journal of Toxicology and Environmental Health. Part A|January 16, 2010
A prospective blinded evaluation of urinary porphyrins verses the clinical severity of autism spectrum disordersDavid A Geier, Janet K Kern, Mark R Geier
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 29, 2010
The relative toxicity of compounds used as preservatives in vaccines and biologicsDavid A Geier, Sarah K Jordan, Mark R Geier
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 30, 2016
A Two-Phase Case-Control Study of Autism Risk Among Children Born From the Late 1990s Through the Early 2000s in the United StatesDavid A Geier, Janet K Kern, Mark R Geier
Toxics|November 18, 2018
Premature Puberty and Thimerosal-Containing Hepatitis B Vaccination: A Case-Control Study in the Vaccine Safety DatalinkDavid A Geier, Janet K Kern, Mark R Geier
Acta Neurobiologiae Experimentalis|July 14, 2009
A prospective study of prenatal mercury exposure from maternal dental amalgams and autism severityDavid A Geier, Janet K Kern, Mark R Geier
Acta Neurobiologiae Experimentalis|July 15, 2010
The biological basis of autism spectrum disorders: Understanding causation and treatment by clinical geneticistsDavid A Geier, Janet K Kern, Mark R Geier
Expert Opinion on Drug Safety|August 9, 2003
A review of hepatitis B vaccinationMark R Geier, David A Geier, Arthur C Zahalsky
Journal of the Neurological Sciences|May 17, 2008
Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety DatalinkHeather A Young, David A Geier, Mark R Geier
Developmental Neurobiology|November 20, 2019
Down syndrome as a genetic model to evaluate the role of oxidative stress and transsulfuration abnormalities in autism spectrum disorder: A 10-year longitudinal cohort studyDavid A Geier, Janet K Kern, Mark R Geier
Maedica|February 13, 2013
A prospective Cross-sectional Cohort Assessment of Health, Physical, and Behavioral Problems in Autism Spectrum DisordersDavid A Geier, Janet K Kern, Mark R Geier
Pageof 13